Shares of RxSight, Inc. (NASDAQ:RXST – Get Free Report) have received a consensus recommendation of “Buy” from the six research firms that are presently covering the stock, MarketBeat.com reports. Six analysts have rated the stock with a buy rating. The average 12-month price objective among brokers that have issued ratings on the stock in the […]